Board of Directors

The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members with Joerg Reinhardt as chairman.

Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)

Joerg Reinhardt, Ph.D., Chairman of the Board of Directors
Chairman
Joerg Reinhardt, Ph.D.
Enrico Vanni, Ph.D., Vice Chairman of the Board of Directors
Vice Chairman | Lead Independent Director
Enrico Vanni, Ph.D.
Nancy C. Andrews, M.D., Ph.D., Member of the Board of Directors
Board member since 2015
Nancy C. Andrews, M.D., Ph.D.
Ton Buechner, Member of the Board of Directors
Board member since 2016
Ton Buechner
Patrice Bula, Member of the Board of Directors
Board member since February 28, 2019
Patrice Bula
Elizabeth (Liz) Doherty, Member of the Board of Directors
Board member since 2016
Elizabeth (Liz) Doherty
Ann Fudge, Member of the Board of Directors
Board member since 2008
Ann Fudge
Bridgette Heller, Member of the Board of Directors
Board member since February 28, 2020
Bridgette Heller
Frans van Houten, Member of the Board of Directors
Board member since 2017
Frans van Houten
Simon Moroney, Member of the Board of Directors
Board member since February 28, 2020
Simon Moroney, D.Phil.
Andreas von Planta, Ph.D., Member of the Board of Directors
Board member since 2006
Andreas von Planta, Ph.D.
Charles L. Sawyers, M.D., Member of the Board of Directors
Board member since 2013
Charles L. Sawyers, M.D.
William T. Winters, Member of the Board of Directors
Board member since 2013
William T. Winters
Charlotte Pamer-Wieser, Ph.D., Corporate Secretary
Corporate Secretary
Charlotte Pamer-Wieser, Ph.D.